Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; Effects of NO synthase inhibition or ET receptor antagonism

British Journal of Pharmacology

Volumn 128, Issue 8, 1999, Pages 1795-1803

  Gardiner, S M ^a   March, J E ^a   Kemp, P A ^a   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Angiotensin; Endothelin; N(G) nitro L arginine methyl ester; Transgenic rats

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN I; ENDOTHELIN; ENDOTHELIN RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HETEROZYGOTE; HYPERTENSION; KIDNEY BLOOD VESSEL; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; TRANSGENE; VASOCONSTRICTION; VASODILATATION;

EID: 0033431858     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702978     Document Type: Article

References (38)

1. ARRIBAS, S., SÁNCHEZ-FERRER, C.F., PEIRÓ, C., PONTE, A., SALAICES, M. & MARÍN, J. (1994). Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2. Gen. Pharmacol., 25, 1163-1170.
2. BALAKRISHNAN, S.M., WANG, H.D., GOPALAKRISHNAN, V., WILSON, T.W. & MCNEILL, J.R. (1996). Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension, 28, 806-809.
3. CARGNELLI, G., ROSSI, G.P., PESSINA, A.C., LUCIANI, S., DEBETTO, P., GANTEN, D., PETERS, J. & BOVA, S. (1998). Changes of blood pressure and aortic strip contractile responses to ET-1 of heterozygous female transgenic rats, TGR (mRen2)27. Pharmacol. Res., 37, 207-211.
4. CHEN, L., MCNEILL, J.R., WILSON, T.W. & GOPALAKRISHNAN, V. (1995). Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin. Hypertension, 26, 83-88.
5. CONRAD, K.P. & WHITTEMORE, S.L. (1992). N(G)-monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am. J. Physiol., 262, R1137-R1144.
6. CORDER, R., LOWRY, P.J., WILKINSON, S.J. & RAMAGE, A.G. (1986). Comparison of the haemodynamic actions of neuropeptide Y, angiotensin II and noradrenaline in anaesthetized cats. Eur. J. Pharmacol., 121, 25-30.
7. DOUGLAS, S.A., EDWARDS, R.M., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995). In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB209670. Br. J. Pharmacol., 114, 405-413.
8. FITZGERALD, S.M., EVANS, R.G., CHRISTY, I.J. & ANDERSON, W.P. (1995). Nitric oxide synthase blockade and renal vascular responses to norepinephrine and endothelin-1 in conscious dogs. J. Cardiovasc. Pharmacol., 25, 979-985.
9. FOLKOW, B. (1982). Physiological aspects of primary hypertension. Physiol. Rev., 62, 347-504.
10. FOZARD, J.R. & PART, M.L. (1992). The role of nitric oxide in the regional vasodilator effects of endothelin-1 in the rat. Br. J. Pharmacol., 105, 744-750.
11. GARDINER, S.M., BENNETT, T. & COMPTON, A.M. (1988). Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J. Auton. Nerv. Syst., 24, 15-27.
12. GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (1998). The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats. Br. J. Pharmacol., 124, 299-306.
13. GARDINER, S.M., MARCH, J.E., KEMP, P.A., MULLINS, J.J. & BENNETT, T. (1995). Haemodynamic effects of losartan and the endothelin antagonist, SB209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Br. J. Pharmacol., 116, 2237-2244.
14. HEINEMANN, A., WACHTER, C.H., PESKAR, B.A. & HOLZER, P. (1997). Dilatation by angiotensin II of the rat femoral bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins. Br. J. Pharmacol., 122, 975-984.
15. HELLER, L.J. & MOHRMAN, D.E. (1998). Comparison of blood pressure responses to intra-arterial and intra-venous injections of angiotensin I, angiotensin II and bradykinin. Life Sci., 62, PL121-PL125.
16. HILGERS, K.F., PETERS, J., VEELKEN, R., SOMMER, M., RUPPRECHT, G., GANTEN, D., LUFT, F.C. & MANN, J.F.E. (1992). Increased vascular angiotensin formation in female rats harboring the mouse ren-2 gene. Hypertension, 19, 687-691.
17. HILGERS, K.F., VEELKEN, R., KREPPNER, I., GANTEN, D., LUFT, F.C., GEIGER, H. & MANN, J.F.E. (1994). Vascular angiotensin and the sympathetic nervous system: do they interact? Am. J. Physiol., 267, H187-H194.
18. JACINTO, S.M., MULLINS, J.J. & MITCHELL K.D. (1999). Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats. Am. J. Physiol., 276, F315-F322.
19. KORNER, P.I., BOBIK, A., ANGUS, J.A., ADAMS, M.A. & FRIBERG, P. (1989). Resistance control in hypertension. J. Hypertens, 7 (Suppl 4): S125-S134.
20. KREKELS, M.M.E., SPIERING, W., SCHAPER, N.C., HOUBEN, A.J.H.M. & DE LEEUW, P.W. (1998). Dissociation between the renal effects of angiotensin I and II in sodium-restricted normal subjects. Cardiovasc. Res., 38, 215-220.
21. LAUTT, W.W. (1989). Resistance or conductance for expression of arterial vascular tone. Microvasc. Res., 37, 230-236.
22. LI, T. & ZIMMERMAN, B.G. (1990). In vivo comparison of renal and femoral vascular sensitivity and local angiotensin generation. Hypertension, 15, 204-209.
23. MOLNÁR, M. & HERTELENDY, F. (1992). Nω-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am. J. Obstet. Gynecol., 166, 1560-1567.
24. MORIGUCHI, A., BROSNIHAN, K.B., KMACAI, H., GANTEN, D. & FERRARIO, C.M. (1994). Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am. J. Physiol., 266, R1273-R1279.
25. 450, eicosanoids in rat renal vasculature. Br. J. Pharmacol., 124, 946-952.
26. MULLINS, J.J., PETERS, J. & GANTEN, D. (1990). Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature, 344, 541-544.
27. NAVAR, L.G., INSCHO, E.W., MAJID, D.SA., IMIG, J.D., HARRISON-BERNARD, L.M. & MITCHELL K.D. (1996). Paracrine regulation of the renal microcirculation. Physiol. Rev., 76, 425-536.
28. 1 receptor gene expression in transgenic (mRen-2)27 rats. Br. J. Pharmacol., 121, 134-140.
29. NOLL, G., LANG, M.G., TSCHUDI, M.R., GANTEN, D. & LÜSCHER, T.F. (1997). Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANGII in Ren-2 rats. Am. J. Physiol., 272, H493-H500.
30. O'LEARY, D.S. (1991). Regional vascular resistance vs. conductance: which index for baroreflex responses? Am. J. Physiol., 260, H632-H637.
31. PINTO, Y.M., BUIKEMA, H., VAN GILST, W.H., SCHOLTENS, E., VAN GEEL, P.-P., DE GRAEFF, P.A., WAGNER, J. & PAUL, M. (1997). Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. J. Mol. Med., 75, 371-377.
32. RODBARD, S. (1971). The burden of the resistance vessels. Circ. Res., 28 (Suppl 1): I-2-I-8.
33. SIGMON, D.H. & BEIERWALTES, W.H. (1993). Angiotensin II: Nitric oxide interaction and the distribution of blood flow. Am. J. Physiol., 265, R1276-R1283.
34. STARK, R.D. (1968). Conductance or resistance? Nature, 217, 779.
35. SYMONS, J.D., MUSCH, T.I., HAGEMAN, K.S. & STEBBINS, C.L. (1999). Regional blood flow responses to acute ANG II infusion: effects of nitric oxide synthase inhibition. J. Cardiovasc. Pharmacol., 34, 116-123.
36. THEODORSSON-NORHEIM, E. (1987). Friedman and Quade test: BASIC computer program to perform non-parametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput. Biol. Med., 17, 85-99.
37. VANHOUTTE, P.M., BOULANGER, C.M., VIDAL, M. & MOMBOULI, J.-V. (1993). Endothelium-derived mediators and the renin-angiotensin system. In: Robertson, J.I.S. & Nicholls, M.G. (eds.). The Renin-Angiotensin System, Vol I: Biochemistry and Physiology. Gower Medical Publishing: London, chapter 29, pp. 1-5.
38. WHITWORTH, C.E., VENIANT, M.M., FIRTH, J.D., CUMMING, A.D. & MULLINS, J.J. (1995). Endothelin in the kidney in malignant phase hypertension. Hypertension, 26, 925-931.